00:01
Hi, I'm Doctor Rhonda Lawes and this is going
to be a discussion on the use of non
stimulants in the treatment of ADHD.
00:07
Now specifically we're going to focus on
antidepressants.
00:11
So we'll talk about the indications for
this.
00:13
But keep in mind these are an off label use.
00:15
And usually off label uses are typically not
as effective as stimulants.
00:20
But there's really good reasons why you
might prescribe this.
00:24
So we have tricyclic antidepressants and
we'll call those TCAs and dopamine reuptake
inhibitors. So these are usually reserved
for clients that have some of the following
experiences. So as you're preparing for
practice these would be some potential use
cases. If your client has had a poor
response to a trial of stimulants of snris or
alpha two adrenergic agonists, this is an
option you could consider.
00:48
Maybe the patient has tried one of those
other medications and they just couldn't
tolerate the adverse effect.
00:54
A TCA or a dopamine reuptake inhibitor might
be a good alternative.
00:59
And lastly, if the client has significant
coexisting conditions like anxiety or
depression, this might be the best choice
for them.
01:08
Now there's a boxed warning given by the FDA
for all antidepressants because of the
increased risk of suicidal thinking and
behavior.
01:16
So you always want to keep that in mind.
01:18
You want to monitor your patients closely
for clinical, worsening suicidal thoughts or
unusual changes in behavior.
01:26
It doesn't mean your client will experience
this, but you want to be on the alert and the
lookout for that. And you want to educate
your clients to report any of these feelings
or thoughts they may be experiencing.
01:37
So let's look at the mechanism of action of
the TCA.
01:41
Now you see we have the presynaptic neuron
and the postsynaptic neuron.
01:46
Look there at the first little bullet point
we have.
01:49
Now this medication a TCA inhibits the
reuptake of norepinephrine and serotonin.
01:55
So you know, anything that inhibits the
reuptake of these Of these neurotransmitters
means more of those substances are going to
be in the synaptic cleft and available to the
brain. So this is what increases the amount
of those neurotransmitters that are
available. Now there are some other
receptors that are affected.
02:11
You've got the serotonin five two.
02:14
You've got the histaminergic H1 and the
alpha one adrenergic and the muscarinic
receptors. So you've got a lot going on with
this one medication.
02:25
There's a wide range of physiological
effects for TCAs for a good reason because
there are so many of those receptors
involved.
02:33
Let's walk through those because we know
we're going to have increased norepinephrine,
increased serotonin.
02:38
You've got the adrenergic impact the
histamine and the muscarinic.
02:42
So let's start with increase in
norepinephrine.
02:44
What does that do for somebody with ADHD.
02:47
Well it helps them address their problems
with inattention and hyperactivity.
02:52
Now it does this because it corrects the
relatively low levels of norepinephrine,
Nephron, particularly in the prefrontal
cortex.
02:59
And that's where you have all the executive
functioning going on.
03:03
Now the increased serotonin that goes to
mood regulation.
03:06
Now this can help the client monitor their
or impact their impulse control by indirectly
modulating their dopamine activity in the
brain.
03:15
Now the adrenergic antagonism is going to
have some cardiovascular effects.
03:19
I'll go into those in detail in just a
minute.
03:21
The histamine antagonism, that's what gives
you the sedative properties and the
muscarinic antagonism has all those
anticholinergic effects.
03:30
So now let's drill down on some of those
adverse effects that can lead to
contraindications with TCAs.
03:36
There is a risk for cardiovascular events
things like heart block, ventricular
arrhythmias and sudden death.
03:44
Now those are the most severe.
03:45
But they can also experience a mild increase
in their diastolic blood pressure and their
pulse rate. Patients on TCAs report weight
gain, which really is not helpful for anyone.
03:56
They don't like the anticholinergic effects,
particularly that dry mouth feeling that they
have. They can feel really tired.
04:03
Another risk is that it can lower the
seizure threshold if the patient has a
history of that. That's something you're
going to want to be aware of or consider not
using this medication.
04:13
Now, rarely this could bring on thoughts of
suicidal ideation.
04:17
So with any medication you want to make sure
you're having that conversation with your
client. Build a relationship of trust while
they feel safe to report that to you.
04:26
Now let's look at the contraindications.
04:28
Now once you remember the adverse effects,
the contraindications are obvious.
04:33
You wouldn't want to give a TCA to anyone
with cardiovascular disease, and particularly
not anyone with any cardiac conduction
abnormalities if they've got arrhythmias.
04:42
Again, that would be a definite and clear
cardiovascular contraindication.
04:47
Also, because it lowers the seizure
threshold, you wouldn't want to give it to
somebody with a seizure disorder, and you
wouldn't want to give it with someone who's
also on a serotonergic agent.
04:59
Now, before you prescribe a TCA, all the
reasons we've just talked about the adverse
effects or contraindications, you want to
make sure that you have a patient's history
and family history. That's very thorough.
05:10
Make sure the parents or guardians are aware
of the risk of suicidal ideation.
05:15
Make sure you get an ECG to screen for
disorders of the cardiac system.
05:19
And consult your Drug Interactions database
to see if there's any interactions with TCAs.
05:24
Now when you're prescribing this, it's
typically formulated as a tablet or a capsule
for oral use. Of course, you're going to
want to start at a low dose.
05:32
You can titrate this medication weekly, but
it needs to be taken every day.
05:37
No drug holidays with TCAs.
05:39
And make sure they monitor the heart rate
and the blood pressure as a baseline.
05:43
And during the treatment.
05:44
Now when you're discontinuing a TCA, make
sure that you taper it to avoid severe
withdrawal effects.